Dania Vázquez‐Blomquist

Targeting of Protein Kinase CK2 in Acute Myeloid Leukemia Cells Using the Clinical-Grade Synthetic-Peptide CIGB-300

Mauro Rosales, George Perez, Ailyn C. Ramòn et al. · Biomedicines · 2021 · 23 citations · Full text

Protein Kinase Ck2, Immunology, Cell Death +17

Selection of reference genes for use in quantitative reverse transcription PCR assays when using interferons in U87MG

Dania Vázquez‐Blomquist, Julio R. Fernández, Jamilet Miranda et al. · Molecular Biology Reports · 2012 · 22 citations

Natural Sciences, Genetics, Gene Recognition +9

Development of a new formulation of interferons (HEBERPAG) for BCC treatment

Iraldo Bello Rivero, Yanelda García-Vega, Carmen Valenzuela‐Silva et al. · Journal of Cancer Research & Therapy · 2013 · 17 citations · Full text

Pharmacokinetic and pharmacodynamic characterization of a new formulation containing synergistic proportions of interferons alpha-2b and gamma (HeberPAG®) in patients with mycosis fungoides: an open-label trial

Yanelda García-Vega, Idrian García‐García, Sonia E. Collazo-Caballero et al. · BMC Pharmacology and Toxicology · 2012 · 14 citations · Full text

Targeting of Protein Kinase CK2 Elicits Antiviral Activity on Bovine Coronavirus Infection

Ailyn C. Ramòn, George Perez, Evelín Caballero et al. · Viruses · 2022 · 12 citations · Full text

Molecular Virology, Protein Kinase Ck2, Viral Pathogenesis +13